Dr. Jefferson G Fernandes is a Neurologist, educator, and global leader in digital health, bridging the gap between innovation and real-world healthcare transformation. With a distinguished career spanning medical education, health management, and cutting-edge research, he is a sought-after advisor for organizations looking to navigate the complexities of telemedicine, AI in healthcare, and digital health strategies.
SPECIS is a healthcare consulting company operating in Brazil and abroad, which is ready to serve you with Dr. Jefferson at the helm.
This project aimed to support hospitals operating within the Unified Health System (SUS) in developing qualified care for patients with acute stroke, through a training program and specialized second opinion…
Teledermatology Project providing specialized medical support to remote communities in the Amazon region, using telecommunication systems and mobile technologies. The patients were…
Tele-education project for medical undergraduate students in which they were introduced to new concepts of medical care: telemedicine, remote second opinion and information and communication…
Transformations and advancements in medicine are happening exponentially. Physicians and healthcare professionals face ongoing challenges with the emergence of disruptive technological innovations, such as advanced genomics and artificial…
Digital transformation is one of the biggest drivers of change in the pharmaceutical industry today. Artificial intelligence, big data and other digital technologies are transforming everything from the research and development of new drugs to the relationships between patients, physicians, and payers.
I’m thrilled to share that I have joined the Federal University of Health Sciences of Porto Alegre (UFCSPA) as a Visiting Professor. In this new role, I’ll be working closely with faculty, students, and partners
This was the general theme of a meeting that Dr Andreas Keck (Syte Institute, Germany) and I held a few days ago at SINDUSFARMA, in São Paulo, with leaders from the pharmaceutical industry in Brazil.
At the end of October 2025, Professor Dame Linda Partridge went to Porto Alegre, Brazil, to participate in another edition of The Future of Medicine event. I took the opportunity to have a conversation with
